BB&T Securities’s Invesco Pharmaceuticals ETF PJP Stock Holding History

BB&T Securities’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-3,444	Closed	-$202K	–	1408
2017 Q1	$202K	Buy	+3,444	New	+$201K	﹤0.01%	1161
2016 Q1	–	Sell	-3,079	Closed	-$215K	–	1224
2015 Q4	$215K	Hold	3,079	–	–	﹤0.01%	1048
2015 Q3	$204K	Buy	+3,079	New	+$240K	﹤0.01%	1004
2015 Q2	–	Sell	-3,579	Closed	-$273K	–	1136
2015 Q1	$273K	Hold	3,579	–	–	0.01%	907
2014 Q4	$238K	Buy	+3,579	New	+$238K	0.01%	970

Other funds holding PJP

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Atria Investments Charlotte, North Carolina $9.98B AUM 26.5% 1-Year Est. Return

BB&T Securities's PJP Position: Q2 2017 in Review

BB&T Securities sold out of Invesco Pharmaceuticals ETF (PJP) in Q2 2017, closing a stake of 3,444 shares — an estimated $202K sold.

BB&T Securities first reported a position in PJP in Q4 2014 and held it in 5 quarters. The position peaked at $273K in Q1 2015. 99 funds tracked by Wall St. Rank hold PJP as of Q2 2017.

BB&T Securities reported no remaining Invesco Pharmaceuticals ETF position as of Q2 2017 after selling out during the quarter.
BB&T Securities sold 3,444 Invesco Pharmaceuticals ETF shares in Q2 2017, an estimated $202K.
BB&T Securities first reported a position in Invesco Pharmaceuticals ETF in Q4 2014 and held it in 5 quarters.
BB&T Securities's Invesco Pharmaceuticals ETF position peaked at $273K in Q1 2015.
99 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2017.

Based on BB&T Securities's 13F filing for Q2 2017, filed 4 Aug 2017.